IMMX
Price
$2.55
Change
+$0.14 (+5.81%)
Updated
Jul 3 closing price
Capitalization
71.09M
59 days until earnings call
INRLF
Price
$3.10
Change
-$0.15 (-4.62%)
Updated
Jun 10 closing price
Capitalization
481.42M
Interact to see
Advertisement

IMMX vs INRLF

Header iconIMMX vs INRLF Comparison
Open Charts IMMX vs INRLFBanner chart's image
Immix Biopharma
Price$2.55
Change+$0.14 (+5.81%)
Volume$101.83K
Capitalization71.09M
Valneva SE
Price$3.10
Change-$0.15 (-4.62%)
Volume$100
Capitalization481.42M
IMMX vs INRLF Comparison Chart in %
Loading...
IMMX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
INRLF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
IMMX vs. INRLF commentary
Jul 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IMMX is a Buy and INRLF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 07, 2025
Stock price -- (IMMX: $2.55 vs. INRLF: $3.10)
Brand notoriety: IMMX and INRLF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: IMMX: 52% vs. INRLF: 6%
Market capitalization -- IMMX: $71.09M vs. INRLF: $496.44M
IMMX [@Biotechnology] is valued at $71.09M. INRLF’s [@Biotechnology] market capitalization is $496.44M. The market cap for tickers in the [@Biotechnology] industry ranges from $316.35B to $0. The average market capitalization across the [@Biotechnology] industry is $2.39B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IMMX’s FA Score shows that 0 FA rating(s) are green whileINRLF’s FA Score has 0 green FA rating(s).

  • IMMX’s FA Score: 0 green, 5 red.
  • INRLF’s FA Score: 0 green, 5 red.
According to our system of comparison, both IMMX and INRLF are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IMMX’s TA Score shows that 6 TA indicator(s) are bullish while INRLF’s TA Score has 2 bullish TA indicator(s).

  • IMMX’s TA Score: 6 bullish, 4 bearish.
  • INRLF’s TA Score: 2 bullish, 3 bearish.
According to our system of comparison, IMMX is a better buy in the short-term than INRLF.

Price Growth

IMMX (@Biotechnology) experienced а +13.84% price change this week, while INRLF (@Biotechnology) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +6.93%. For the same industry, the average monthly price growth was +17.38%, and the average quarterly price growth was -0.11%.

Reported Earning Dates

IMMX is expected to report earnings on Sep 03, 2025.

Industries' Descriptions

@Biotechnology (+6.93% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
INRLF($481M) has a higher market cap than IMMX($71.1M). INRLF YTD gains are higher at: 48.230 vs. IMMX (15.909). IMMX has higher annual earnings (EBITDA): -21.62M vs. INRLF (-55.24M). INRLF has more cash in the bank: 153M vs. IMMX (15.9M). IMMX has less debt than INRLF: IMMX (1.06M) vs INRLF (211M). INRLF has higher revenues than IMMX: INRLF (186M) vs IMMX (0).
IMMXINRLFIMMX / INRLF
Capitalization71.1M481M15%
EBITDA-21.62M-55.24M39%
Gain YTD15.90948.23033%
P/E RatioN/AN/A-
Revenue0186M-
Total Cash15.9M153M10%
Total Debt1.06M211M1%
FUNDAMENTALS RATINGS
INRLF: Fundamental Ratings
INRLF
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
49
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
96
PRICE GROWTH RATING
1..100
51
P/E GROWTH RATING
1..100
80
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
IMMXINRLF
RSI
ODDS (%)
Bearish Trend 4 days ago
85%
Bullish Trend 4 days ago
63%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
82%
N/A
Momentum
ODDS (%)
Bullish Trend 4 days ago
84%
Bullish Trend 4 days ago
67%
MACD
ODDS (%)
Bearish Trend 4 days ago
90%
N/A
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
86%
Bullish Trend 4 days ago
60%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
68%
Advances
ODDS (%)
Bullish Trend 4 days ago
83%
N/A
Declines
ODDS (%)
Bearish Trend 7 days ago
90%
N/A
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
90%
N/A
Aroon
ODDS (%)
Bullish Trend 4 days ago
76%
Bearish Trend 4 days ago
63%
View a ticker or compare two or three
Interact to see
Advertisement
IMMX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
INRLF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
HSMFX12.340.08
+0.65%
Hartford Small Cap Value F
TRVPX18.400.10
+0.55%
Nuveen Mid Cap Value Premier
USEMX23.820.11
+0.46%
Victory Emerging Markets
AZEMX12.340.04
+0.33%
Alger Emerging Markets Z
AEIUX8.770.02
+0.23%
American Century Equity Income R5

IMMX and

Correlation & Price change

A.I.dvisor indicates that over the last year, IMMX has been loosely correlated with IMTX. These tickers have moved in lockstep 33% of the time. This A.I.-generated data suggests there is some statistical probability that if IMMX jumps, then IMTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IMMX
1D Price
Change %
IMMX100%
+16.44%
IMTX - IMMX
33%
Loosely correlated
+2.15%
COGT - IMMX
33%
Poorly correlated
+2.29%
XERS - IMMX
32%
Poorly correlated
+0.42%
RNAC - IMMX
31%
Poorly correlated
-1.41%
SYRE - IMMX
31%
Poorly correlated
+1.68%
More

INRLF and

Correlation & Price change

A.I.dvisor indicates that over the last year, INRLF has been loosely correlated with VALN. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if INRLF jumps, then VALN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To INRLF
1D Price
Change %
INRLF100%
N/A
VALN - INRLF
42%
Loosely correlated
+1.57%
IKT - INRLF
22%
Poorly correlated
+2.16%
IMMX - INRLF
21%
Poorly correlated
+16.44%
NBTX - INRLF
20%
Poorly correlated
+2.96%
VXRT - INRLF
20%
Poorly correlated
N/A
More